Leukemia stem cells (LSCs) have been reported to participate in drug resistance and recurrence of AML24,25, and GDYO significantly decreased the frequency of leukemia progenitor and stem cells in DNMT3A-mutant cells (Fig. 2h, i and Supplementary Fig. 9c). The gene discussed is DNMT3A; the disease is leukemia.